Miraclid


Indications and Reactions:

Role Indications Reactions
Secondary
Allogenic Bone Marrow Transplantation Therapy 28.8%
Pancreatitis 15.3%
Immunosuppression 8.5%
Drug Use For Unknown Indication 6.8%
Pneumonia 6.8%
Prophylaxis 6.8%
Adhesiolysis 3.4%
Febrile Neutropenia 3.4%
Sedative Therapy 3.4%
Shock 3.4%
Acute Myeloid Leukaemia Recurrent 1.7%
Analgesic Therapy 1.7%
Antibiotic Prophylaxis 1.7%
Hypertension 1.7%
Muscle Relaxant Therapy 1.7%
Procoagulant Therapy 1.7%
Sedation 1.7%
Urine Output 1.7%
Pancreatitis 17.6%
Small Cell Lung Cancer Stage Unspecified 11.8%
Anaphylactic Shock 5.9%
Brain Stem Haemorrhage 5.9%
Cerebral Haemorrhage 5.9%
Circulatory Collapse 5.9%
Eosinophilia 5.9%
Multi-organ Failure 5.9%
Pneumonia 5.9%
Reye's Syndrome 5.9%
Shock 5.9%
Urticaria 5.9%
Vasculitis 5.9%
Ventricular Fibrillation 5.9%
Concomitant
Drug Use For Unknown Indication 19.3%
Prophylaxis 13.6%
Product Used For Unknown Indication 7.2%
Shock 6.6%
Cardiac Failure 4.9%
Meningitis 4.9%
Pain 3.9%
Immunosuppression 3.8%
Premedication 3.8%
Infection Prophylaxis 3.6%
Sepsis 3.6%
Stem Cell Transplant 3.3%
Disseminated Intravascular Coagulation 3.0%
Allogenic Bone Marrow Transplantation Therapy 2.8%
Sedation 2.8%
Arrhythmia 2.6%
Eating Disorder 2.6%
Fluid Replacement 2.6%
Pneumonia 2.6%
Pancreatitis 2.5%
Sepsis 16.2%
Drug Rash With Eosinophilia And Systemic Symptoms 8.1%
Rash 6.8%
Superinfection 6.8%
Thrombocytopenia 6.8%
Toxic Epidermal Necrolysis 6.8%
Hepatic Function Abnormal 5.4%
Laryngopharyngitis 4.1%
Peritonitis 4.1%
Pyrexia 4.1%
Renal Failure Acute 4.1%
Septic Shock 4.1%
Vomiting 4.1%
Acute Respiratory Failure 2.7%
Anaphylactic Shock 2.7%
Death 2.7%
Hyperbilirubinaemia 2.7%
Hypernatraemia 2.7%
Hypertension 2.7%
Ileus 2.7%

Drug Data